mediVR
mediVR is a Japanese medical device company that develops mediVR Kagura, a VR-based rehabilitation system delivering proprietary Somato-Cognitive Coordination Therapy to hospitals, rehabilitation clinics, nursing homes, and self-pay patients across Japan and (newly) the US.
- Company typePrivate
- Founded2016
- HeadquartersOsaka, Japan
- Headcount1–10
- GTM type—
- Offering—
What mediVR does
mediVR (株式会社mediVR) is a Japanese medical device company founded in June 2016 as an Osaka University spin-off by cardiologist Masahiko Hara. The company develops and commercializes mediVR Kagura, a Class I medical device in Japan (and Class 2 FDA-registered in the United States) that delivers proprietary Somato-Cognitive Coordination Therapy (SCCT) for neurological, orthopedic, and pediatric rehabilitation. The system is built on an HTC VIVE Pro Eye head-mounted display paired with motion-tracking controllers and proprietary calibration and game software that quantifies patient reaching ability across six angles and three distances, manages adaptive cognitive load, and uses a multi-channel biofeedback approach to elicit voluntary movement in patients who cannot stand or who have reduced cognitive function.
The technology stack is protected by 26+ granted Japanese patents covering sensory-conflict VR sickness prevention (reducing incidence to below 0.5%), cognitive age estimation, cognitive load control, 3D calibration, and brain-reorganization biofeedback. A web-based management dashboard captures patient templates, play history, and CSV exportable reporting, while five proprietary game types vary cognitive load across rehabilitation phases.
mediVR operates a dual business model. The primary enterprise motion is direct sales and leasing of mediVR Kagura equipment to medical institutions — universities, rehabilitation hospitals, nursing homes, and day care facilities — through a structured sales process including 2.5-hour demonstrations, 2-week free demo loans with four-plus therapist follow-up sessions, and ongoing post-sale support. As of 2026, more than 100 partner facilities across Japan use the device, and cumulative treatment sessions have reached 340,000. The secondary motion consists of three company-operated mediVR Rehabilitation Centers (Osaka, Mitaka/Tokyo, Fukuoka) that deliver therapy directly to self-pay patients under an industry-first outcome-based pricing model, where patients pay only when individually set rehabilitation milestones are achieved and maintained for one week; a 1,000 yen scheduling fee applies per session. International expansion is underway following February 2024 FDA Class 2 registration, with joint research partnerships established at the University of Texas at Austin (June 2025) and UCLA (June 2026) to support US market entry.
mediVR firmographics
Firmographics- Name
- mediVR
- Legal name
- 株式会社mediVR
- Website
- https://medivr.jp
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- mediVR is a Japanese medical device company that develops mediVR Kagura, a VR-based rehabilitation system delivering proprietary Somato-Cognitive Coordination Therapy to hospitals, rehabilitation clinics, nursing homes, and self-pay patients across Japan and (newly) the US.
- Ownership category
- akta.pro rank
mediVR industry classification
Industry- Product category
- VR Rehabilitation Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Home Health Equipment Rental (532283)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Healthcare & Assistive Robotics (HDAAAIAC)
- akta.pro secondary industries
- Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination) (HLALABAG)
Keywords
Where mediVR is headquartered
LocationHeadquarters
- HQ city
- Osaka
- HQ country
- Japan
- HQ region
- Asia
Offices3 records
Markets served
mediVR business model
Business model- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- mediVR Kagura Equipment Sales and Lease: Sale or lease of the mediVR Kagura rehabilitation device (Class I medical device, general name: 測定機能付自力運動訓練装置) to medical institutions including universities, rehabilitation hospitals, nursing homes, and day care facilities. Purchase or lease options are offered.
- Outcome-Based Self-Pay Rehabilitation Services: mediVR Rehabilitation Centers (in Osaka, Mitaka/Tokyo, and Fukuoka) operate on an industry-first outcome-based pricing model where patients pay only upon achievement of individually set rehabilitation milestones. A 1,000 yen/session scheduling fee applies regardless of outcome. Traditional time-based pricing is also available as an alternative. The company also provides social contribution pricing for pediatric and rare disease patients at significantly reduced rates.
- Professional Services and Training: Training and clinical support services for institutions implementing mediVR Kagura, including therapist training, onboarding support (minimum 4 follow-up sessions during demo period), and ongoing support. A domestic training/observation program for medical professionals is also offered.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Outcome Based/ Performance | Pay-as-you-go | Outcome-based pricing at mediVR Rehabilitation Centers — payment upon milestone achievement |
| Subscription | Pay-as-you-go | Time-based pricing (alternative) at mediVR Rehabilitation Centers |
| One time/ perpetual license | Multi-year contract | Equipment purchase or lease for medical institutions |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
mediVR product offering
Product offeringCore offering
mediVR develops and manufactures the mediVR Kagura, a Class I medical device in Japan (FDA Class 2 registered) that uses VR head-mounted displays, motion-tracking controllers, and proprietary Somato-Cognitive Coordination Therapy (SCCT) software to deliver seated dual-task rehabilitation exercises. The system is sold or leased to medical institutions and is also delivered directly to patients through three company-operated rehabilitation centers in Japan that operate on an industry-first outcome-based pricing model.
Product overview
mediVR offers a single unified product portfolio centered on its proprietary VR rehabilitation device, mediVR Kagura, which is classified as a Class I medical device in Japan (self-exercise training apparatus with measurement function, 測定機能付自力運動訓練装置) and registered as a Class 2 device with the US FDA. The Kagura device is sold to medical institutions (hospitals, rehabilitation centers, nursing homes, daycare facilities) across Japan, while the company also operates three owned Rehabilitation Centers in Osaka, Tokyo (Mitaka), and Fukuoka that provide direct therapy services to patients using the Kagura system. The core product and service offering are tightly integrated, with the rehabilitation centers serving both as an operational reference site and a direct revenue channel, while the devices are sold to third-party facilities. Tutorial videos provide onboarding and training content for users of the system.
Differentiator
Problem solved
Functional benefit
Brands
- mediVRカグラ (mediVR Kagura): VR rehabilitation medical device for Somato-Cognitive Coordination Therapy (SCCT), registered as a Class I medical device (測定機能付自力運動訓練装置).
- mediVRリハビリテーションセンター (mediVR Rehabilitation Center)
Products and services
- mediVR Kagura (mediVRカグラ) Class I medical device (self-exercise training apparatus with measurement function) that uses virtual reality technology to deliver Somato-Cognitive Coordination Therapy (SCCT) for rehabilitation. Tracks patient movements in 3D space via VR controllers, renders interactive training tasks on a head-mounted display, and quantitatively measures rehabilitation outcomes. Sold or leased to medical institutions including universities, rehabilitation hospitals, nursing homes, and day care facilities across Japan.
- mediVR Rehabilitation Centers (mediVRリハビリテーションセンター) Self-pay rehabilitation clinics in Osaka, Tokyo (Mitaka), and Fukuoka providing SCCT therapy using mediVR Kagura under therapist supervision. Operates on an industry-first outcome-based pricing model where patients pay only when individually set rehabilitation milestones are achieved and maintained for one week. A 1,000 yen/session scheduling fee applies regardless of outcome. Alternative time-based pricing also available, with social contribution pricing at 1/4 to 1/10 standard rates for pediatric and rare disease patients.
- Professional Training and Clinical Support Services Training and clinical support services provided to medical institutions implementing mediVR Kagura, including therapist training, onboarding support (minimum 4 follow-up sessions during the 2-week demo period), weekly post-sale therapist support for the first month, and a domestic training/observation program for medical professionals.
Quantifiable outcome
- VR sickness incidence reduced to below 0.5% vs. ~30% in general VR use
- +3 more outcomes
Companies that use mediVR
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles2 records
mediVR technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature8 records
mediVR partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- University of California, Los Angeles (UCLA)coreJoint research partnership initiated in June 2026 as part of mediVR's international expansion strategy. Builds on the company's FDA Class 2 medical device registration and prior research collaboration with University of Texas at Austin.
- Japan Agency for Medical Research and Development (AMED)coremediVR was selected for AMED's Digital Healthcare Development and Acceleration Project in November 2025. This government-backed research funding supports the company's clinical research and product development in digital healthcare.
- University of Texas at AustincoreJoint research partnership established in June 2025 focused on mediVR Kagura and Somato-Cognitive Coordination Therapy. Represents one of mediVR's key international research collaborations to build evidence for the US market, leveraging FDA Class 2 registration achieved in February 2024.
- Mitaka City, TokyocorePartnership agreement signed with Mitaka City in December 2022. The city hosts the mediVR Rehabilitation Center Mitaka Satellite within its welfare facility (福祉Laboどんぐり山). Represents a unique public-private partnership model for VR rehabilitation services in Japan.
- J-Startup Program (Ministry of Economy, Trade and Industry)minorSelected for the government-backed J-Startup program in June 2018, which provides startup cultivation support including mentorship, networking, and international expansion assistance.
- Osaka UniversitycoremediVR was founded as an Osaka University spin-off venture in June 2016. Founder Masahiko Hara, a cardiologist, developed the technology based on clinical observations at Osaka University-affiliated institutions. The university's academic backing underpins the company's scientific credibility.
Scale indicators6 records
Recent moves11 records
Expansion highlights6 records
mediVR competitors and assessment
Company assessmentDirect peers
- Penumbra (REAL Immersive System): Penumbra's REAL Immersive System is a commercially available VR rehabilitation platform for stroke and neurorehabilitation in clinical settings. Direct competitor with FDA-cleared VR rehab device targeting similar patient populations and clinical use cases as mediVR Kagura.
- MindMaze: MindMaze develops digital neurotherapeutics including VR-based platforms for stroke recovery, brain injury rehabilitation, and neurological conditions. Swiss-based but globally active, it competes with mediVR in the VR neurorehabilitation market with significantly more capital and US presence.
- XRHealth: XRHealth operates a VR telehealth platform providing immersive therapy for physical rehabilitation, cognitive training, and pain management. Targets similar clinical applications as mediVR with a software-as-a-service model delivered via consumer VR hardware.
- AppliedVR: AppliedVR develops FDA-authorized VR therapeutics, with flagship product EaseVRx for chronic pain. Targets one of mediVR's use cases (chronic pain) with regulatory-authorized VR therapy, representing an adjacent indication overlap.
- Neuro Rehab VR: Neuro Rehab VR builds VR-based rehabilitation exercises for physical therapy clinics and hospitals, focused on functional movement and motor recovery. Direct peer in clinical VR rehabilitation with comparable target customers and use cases.
- Saebo: Saebo manufactures and distributes rehabilitation equipment for stroke and neurological injury recovery, including VR-augmented therapy tools. Competes with mediVR in the upper-limb and neurological rehabilitation equipment market sold to clinics.
Emerging players
- BehaVR: BehaVR develops VR-based digital therapeutics for mental health, chronic pain, and behavioral health conditions. Adjacent VR therapeutic competitor focused on psychological and pain indications that overlap with mediVR's chronic pain applications.
Broad incumbents
- Hocoma (DIH): Hocoma, now part of DIH, is a global leader in robotic rehabilitation devices including Lokomat, Armeo, and Erigo product lines. Established incumbent in clinical rehabilitation technology with broader portfolio and global hospital relationships, competing in adjacent rehab robotics category.
- Tyromotion: Tyromotion is an Austrian-based manufacturer of robotic and computer-assisted rehabilitation devices for upper and lower extremity therapy. Established rehabilitation technology incumbent with similar clinical target customers and neurological rehab focus as mediVR.
- Ekso Bionics: Ekso Bionics develops wearable exoskeletons and robotic rehabilitation devices for stroke, spinal cord injury, and gait rehabilitation. Public company competing in the broader robotic rehabilitation equipment market serving similar clinical end-users.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
mediVR social profiles
Digital presencemediVR compliance and trust
Trust signalCompliance4 records
mediVR financial estimates
Financial estimateRevenue estimate
Valuation estimate
mediVR leadership team
Management profileNumber of profiles
Profiles11 records
mediVR funding detail
Funding detailFunding overview
Funding rounds2 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
mediVR M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about mediVR
What does mediVR do?
mediVR develops and manufactures the mediVR Kagura, a Class I medical device in Japan (FDA Class 2 registered) that uses VR head-mounted displays, motion-tracking controllers, and proprietary Somato-Cognitive Coordination Therapy (SCCT) software to deliver seated dual-task rehabilitation exercises. The system is sold or leased to medical institutions and is also delivered directly to patients through three company-operated rehabilitation centers in Japan that operate on an industry-first outcome-based pricing model.
Is mediVR a public or private company?
mediVR is a private company. It is classified as venture growth investor backed and is currently operating.
When was mediVR founded?
mediVR was founded in 2016. It employs 1 to 10 people.
Where is mediVR based?
mediVR is headquartered in Osaka, Japan, in the Asia region.
How does mediVR make money?
Three revenue lines are on record. mediVR Kagura Equipment Sales and Lease is the primary driver. The others are outcome-Based Self-Pay Rehabilitation Services and professional Services and Training.
Who are mediVR's main competitors?
Direct peers on record are Penumbra (REAL Immersive System), MindMaze, XRHealth, AppliedVR, Neuro Rehab VR and Saebo. BehaVR is listed as an emerging player. Broad incumbents are Hocoma (DIH), Tyromotion and Ekso Bionics.
Does mediVR have an API?
No public API is recorded for mediVR.
What industry is mediVR in?
mediVR's product category is VR Rehabilitation Medical Devices. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLACAFAH, Virtual Nursing, Telemonitoring & Command Center Platforms. Its NAICS code is 339112 and its SIC code is 3841.